Trial Profile

Examine the comparative availability of DPP-4 Inhibitor versus Alfa-glucosidase inhibitor for the type 2 diabetic patient who was treated with Pioglitazone or Metformin.

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 02 Jul 2013

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Sitagliptin (Primary) ; Miglitol; Voglibose
Indications Type 2 diabetes mellitus
Focus Therapeutic Use

Most Recent Events

29 Jun 2013 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan record.
23 Jun 2013 Results presented at the 73rd Annual Scientific Sessions of the American Diabetes Association.
02 May 2013 Status changed from not yet recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com